Eisaku Nakamura
Direttore/Membro del Consiglio presso KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Posizioni attive di Eisaku Nakamura
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/03/2016 | - |
| Independent Dir/Board Member | 01/03/2016 | - | |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Direttore/Membro del Consiglio | 29/03/2018 | - |
| Independent Dir/Board Member | 29/03/2018 | - | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | 01/01/2017 | - |
| Direttore/Membro del Consiglio | 01/09/2013 | 01/01/2017 |
Storia della carriera di Eisaku Nakamura
Precedenti posizioni note di Eisaku Nakamura
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACUCELA INC | Direttore/Membro del Consiglio | 01/05/2015 | - |
Statistiche
Distribuzione geografica
| Giappone | 4 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| D. WESTERN THERAPEUTICS INSTITUTE, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
| KOINOBORI Associate, Inc. |
- Borsa valori
- Insiders
- Eisaku Nakamura
- Esperienza
